Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Augustin Metge"'
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.
Autor:
Guillaume Grenet, Shams Ribault, Giao Bao Nguyen, Faustine Glais, Augustin Metge, Thomas Linet, Behrouz Kassai-Koupai, Catherine Cornu, Théodora Bejan-Angoulvant, Sylvie Erpeldinger, Rémy Boussageon, Aurore Gouraud, Fabrice Bonnet, Michel Cucherat, Philippe Moulin, François Gueyffier
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217701 (2019)
BackgroundThe last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication.
Externí odkaz:
https://doaj.org/article/b80e052c1b1248caae71b05d7b6683f6
Autor:
Jean Luc Fellahi, Justine Lanier Demma, Anthony Martelin, Caroline Giroudon, Augustin Metge, Pascal Chiari, Matteo Pozzi, William Fornier, Xavier Armoiry, Catherine Koffel, Jean-François Obadia
Publikováno v:
Vascular Medicine
Vascular Medicine, 2020, 25 (5), pp.460-467. ⟨10.1177/1358863x20944469⟩
Vascular Medicine, SAGE Publications, 2020, 25 (5), pp.460-467. ⟨10.1177/1358863x20944469⟩
Vascular Medicine, 2020, 25 (5), pp.460-467. ⟨10.1177/1358863x20944469⟩
Vascular Medicine, SAGE Publications, 2020, 25 (5), pp.460-467. ⟨10.1177/1358863x20944469⟩
High-risk pulmonary embolism (PE) requires hemodynamic and respiratory support along with reperfusion strategies. Recently updated European guidelines assign a low class of recommendation to extracorporeal membrane oxygenation (ECMO) for high-risk PE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17110e28de76e3e6b27ba22e8c7b9743
https://www.hal.inserm.fr/inserm-03261175
https://www.hal.inserm.fr/inserm-03261175
Autor:
Aurore Gouraud, Catherine Cornu, Behrouz Kassai-Koupai, Theodora Bejan-Angoulvant, Thomas Linet, François Gueyffier, Rémy Boussageon, Sylvie Erpeldinger, Faustine Glais, Augustin Metge, Michel Cucherat, Philippe Moulin, Fabrice Bonnet, Shams Ribault, Giao Nguyen, Guillaume Grenet
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2019, 14 (6), pp.e0217701. ⟨10.1371/journal.pone.0217701⟩
PLoS ONE, 2019, 14 (6), pp.e0217701. ⟨10.1371/journal.pone.0217701⟩
PLoS ONE, Vol 14, Iss 6, p e0217701 (2019)
PLoS ONE, Public Library of Science, 2019, 14 (6), pp.e0217701. ⟨10.1371/journal.pone.0217701⟩
PLoS ONE, 2019, 14 (6), pp.e0217701. ⟨10.1371/journal.pone.0217701⟩
PLoS ONE, Vol 14, Iss 6, p e0217701 (2019)
BackgroundThe last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1a7a5b0ee7d0501aa040aa60b30e1b
https://hal.archives-ouvertes.fr/hal-02195250
https://hal.archives-ouvertes.fr/hal-02195250
Autor:
Augustin Metge, Michel Cucherat, Gia Bao Nguyen, François Gueyffier, Thomas Linet, Catherine Cornu, Guillaume Grenet, Shams Ribault, A. Lajoinie, Philippe Moulin
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2017, 31 (3), pp.258-264. ⟨10.1111/fcp.12263⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2017, 31 (3), pp.258-264. ⟨10.1111/fcp.12263⟩
Fundamental and Clinical Pharmacology, Wiley, 2017, 31 (3), pp.258-264. ⟨10.1111/fcp.12263⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2017, 31 (3), pp.258-264. ⟨10.1111/fcp.12263⟩
International audience; The aim of this study was to propose a ranking of the currently available antidiabetic drugs, regarding vascular clinical outcomes, in patients with type 2 diabetes, through a network meta-analysis approach. Randomized clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02859bf104a4110adc06e31d223da610
https://pubmed.ncbi.nlm.nih.gov/28036112
https://pubmed.ncbi.nlm.nih.gov/28036112